title: Increased cholesterol levels during paroxetine administration in healthy men.
abstract: BACKGROUND
  Despite the frequent use of selective serotonin reuptake inhibitors in patients with coronary heart disease (CHD), their effects on plasma lipid levels have not been systematically investigated. Our objective was to assess the effects of 8 weeks of paroxetine administration on plasma cholesterol and triglyceride levels.
  
  
  METHODS
  Blood samples were collected at baseline, after 8 weeks of paroxetine administration, and post-discontinuation in 18 healthy male volunteers.
  
  
  RESULTS
  In the 16 of 18 patients whose plasma levels of paroxetine indicated an unequivocal compliance to treatment, paroxetine administration induced an 11.5% increase in low-density lipoprotein cholesterol (LDL-C), which normalized after paroxetine discontinuation.
  
  
  CONCLUSIONS
  The magnitude of the paroxetine-induced increase in LDL-C would lead to a minor increase in CHD risk in a minority of healthy male volunteers without associated CHD risk factors but might increase LDL-C sufficiently to warrant therapeutic intervention in patients with established CHD, based on the National Cholesterol Education Program guidelines.
authors.affiliation: Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Lara
authors.forename: Glen B
authors.initials: GB
authors.lastname: Baker
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Archer
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Le Mellédo
mesh_terms: D000328:Adult; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000097:blood; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000139:chemically induced; D008297:Male; D017374:Paroxetine / Q000008:administration & dosage / Q000009:adverse effects*; D012016:Reference Values; D012306:Risk; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D014280:Triglycerides / Q000097:blood*
chemical_list: D002784:Cholesterol; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D014280:Triglycerides